About this item:

232 Views | 397 Downloads

Author Notes:

Correspondence to: Mikhael El-Chami, MD, Medicine-Division of Cardiology- Section of Electrophysiology, Emory University School of Medicine, Atlanta, USA. E-mail: melcham@emory.edu

Disclosure: Mikhael El-Chami is a consultant for Boston Scientific and Medtronic.

Subject:

Keywords:

  • Inappropriate shocks
  • Subcutaneous ICD
  • Sudden Cardiac death
  • Transvenous ICD

The subcutaneous implantable cardioverter defibrillator––review of the recent data

Tools:

Journal Title:

Journal of geriatric cardiology : JGC

Volume:

Volume 15, Number 3

Publisher:

, Pages 222-228

Type of Work:

Article | Final Publisher PDF

Abstract:

The subcutaneous implantable cardioverter defibrillators (SICD) is an alternative to the transvenous ICD for the prevention of sudden cardiac death (SCD). Multiple studies have shown that the SICD is safe and effective in treating ventricular arrhythmias. While earlier studies mainly enrolled younger patients with channelopathies, more recent reports included patients with “typical” indications for ICD therapy for the prevention of SCD. In this review we summarize the data available to date on the SICD while highlighting its pros and cons.

Copyright information:

© 2018 JGC All rights reserved.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/).

Creative Commons License

Export to EndNote